Immunohistochemical Expression of Cell Cycle/Apoptosis Regulators and Epidermal Growth Factor Receptor in Pediatric Intracranial Ependymomas

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Child Neurology

• Publication date

  2011-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/0883073810378750PMID 20713981
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ependymoma: An Update

  2009cited by this paper
• Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas

  2008cited by this paper
• Identification of Gains on 1q and Epidermal Growth Factor Receptor Overexpression as Independent Prognostic Markers in Intracranial Ependymoma

  2006cited by this paper
• Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas

  2006cited by this paper
• Expression of p53, EGFR, pRb and bcl-2 Proteins in Pediatric Glioblastoma Multiforme: A Study of 54 Patients

  2005cited by this paper
• Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors Part 5: apoptosis and cell cycle

  2005cited by this paper
• Proliferation- and Apoptosis-related Proteins in Intracranial Ependymomas: An Immunohistochemical Analysis

  2004influential reference
• Pediatric Intracranial Ependymomas: Prognostic Relevance of Histological, Immunohistochemical, and Flow Cytometric Factors

  2003cited by this paper
• Immunohistochemical Markers for Prognosis of Ependymal Neoplasms

  2002cited by this paper
• Recent advances in paediatric neuro-oncology

  2002cited by this paper
• p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers.

  1999influential reference
• Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.

  1998cited by this paper
• Treatment of ependymomas. Clinical and non-clinical factors influencing prognosis: a review.

  1997cited by this paper
• Bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study

  1996cited by this paper
• Epidermal growth factor receptors on ependymomas and other brain tumors.

  1990cited by this paper

• Immunohistochemical Expression of p27Kip1, p57Kip2, Cyclin D1, Nestin, and Ki-67 in Ependymoma

  2022cites this paper
• Ependymal Tumors

  2022cites this paper
• Spinal Tumors

  2022cites this paper
• Visualizing Cell Cycle Phase Organization and Control During Neural Lineage Elaboration

  2020cites this paper
• Supratentorial Ependymoma: A Rare Presentation in an Adolescent

  2019cites this paper
• Pediatric ependymoma: GNAO1, ASAH1, IMMT and IPO7 protein expression and 5-year prognosis correlation.

  2019cites this paper
• Molecular Characteristics of Pediatric Ependymomas: A Systematic Review

  2019cites this paper
• Supratentorial ependymomas in children: Analysis of nine cases

  2013cites this paper
• Prognostic Factors in Supratentorial Ependymomas

  2013cites this paper
• EGFR as a predictor of relapse in myxopapillary ependymoma

  2012cites this paper
• Current world literature.

  2012cites this paper